Home » Topics » BioWorld Science

BioWorld Science
RSS

RosVivo signs material transfer agreement with Lilly for RSVI-301 for diabetes

Feb. 22, 2022

Novel Hsp90/HDAC dual inhibitor shows antifungal activity against azole-resistant Candida albicans

Feb. 22, 2022

Shaanxi Synthetic Pharmaceutical presents new thiobenzopyran compounds

Feb. 22, 2022

Apotex patents new antiviral compounds

Feb. 22, 2022

Chinese investigators identify Toll-like receptor antagonists

Feb. 22, 2022

Discovery of KP-1, an antifibrotic peptide that ameliorates renal fibrosis in vivo

Feb. 22, 2022

Betta Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Feb. 22, 2022

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Feb. 22, 2022

New curcumin derivatives show activity against non-small lung cancer

Feb. 22, 2022

CC40.8 antibody confers protection against SARS-CoV-2 infection

Feb. 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...